Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis

doi:10.3748/wjg.v13.i8.1208

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3207)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

267

HTML

2325

Figures (1-5)

344

Tables (1-2)

271

Sum=3207

Feb 28, 2007 (publication date) through Apr 15, 2025

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Feb 28, 2007; 13(8): 1208-1213
Published online Feb 28, 2007. doi: 10.3748/wjg.v13.i8.1208

Full Size Figure Download Figure

Figure 1 RT-PCR (A) and Western-blotting analysis (B) of MK expression in human umbilical vein endothelial cells (HUVEC) after transfection with 0. 4 μmol/L MK-AS (lane 4), MK-SEN (lane 3), Lipofectin alone (lane 2) for 24 h. Lane 1 represents cells without transfection. GAPDH and β-actin were used as control respectively.

Citation: Dai LC, Wang X, Yao X, Lu YL, Ping JL, He JF. Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis. World J Gastroenterol 2007; 13(8): 1208-1213
URL: https://www.wjgnet.com/1007-9327/full/v13/i8/1208.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i8.1208